The duration of use and efficacy of resuscitative endovascular balloon occlusion of the aorta (REBOA) is limited by distal ischemia. We developed a hybrid endovascular-extracorporeal circuit variable aortic control (VAC) device to extend REBOA duration in a lethal model of hemorrhagic shock to serve as an experimental surrogate to further the development of endovascular VAC (EVAC) technologies.
ndovascular techniques are a less invasive and more efficient way to manage vascular injury and shock, [1] [2] [3] [4] [5] [6] and resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as an alternative to resuscitative thoracotomy with aortic clamping. However, despite promising reports and the development of smaller-caliber REBOA devices, concerns exist including distal ischemia, reperfusion injury, and rebound hypotension upon deflation of the balloon. 2, 3, 5 In addition, the effects of prolonged supraphysiologic pressure proximal to the balloon may damage the heart, lungs, and brain. These limitations notwithstanding, the less invasive nature of REBOA makes it attractive for aortic control, and the development of new approaches to this procedure provide great opportunity for therapeutic advances.
While REBOA is effective at restoring proximal perfusion, there is a time threshold beyond which the deleterious effects of aortic occlusion outweigh its initial benefit. However, for clinical scenarios in which the time interval between REBOA and definitive surgical management exceeds this threshold, a more advanced strategy is needed. 7 Variable or partial aortic occlusion that permits a controlled amount of distal perfusion while maintaining proximal aortic pressure is one strategy that may extend the window for endovascular therapies. Variable aortic control (VAC) may be particularly useful if used following an initial period of complete aortic occlusion that promotes distal hemostasis and maximizes proximal perfusion. VAC invokes the principle of permissive hypotension in an attempt to minimize hemorrhage and promote clot stabilization in the area of vascular disruption (e.g., liver, kidney, spleen, or pelvis). 8 This strategy is effective not only because reduced blood pressure promotes clot stabilization but also because regional blood flow is reduced in the face of hypovolemia. While the interaction of pressure, vascular tone, and blood flow varies with each injury scenario, it must be considered as new approaches to aortic control are explored. Regulated VAC is predicated on a new concept of "permissive regional hypoperfusion" that achieves equilibrium among (1) reduced perfusion pressure to promote clot stabilization, (2) a low rate of distal flow to mitigate compensatory vasodilation and provide tissue perfusion, and (3) the avoidance of undue bleeding or exsanguination.
Although not yet widely described in the management of trauma and hemorrhagic shock, VAC-like procedures are used in cardiac failure, ischemic stroke, and the deployment of aortic stent grafts. 9 Recognizing that blood flow across any REBOA device involves the interplay of hemodynamics, ongoing blood loss, and changes in aortic diameter, automation will be required to continuously adjust the degree of aortic occlusion and account for other factors associated with the patient, the injury, and the clinical setting. When developed, automated endovascular VAC (EVAC) combined with the judicious use of resuscitative fluid has the potential to sustain an injured patient for a longer period before definitive hemostasis when compared with existing technology.
In the absence of such an automated endovascular device, a translational model is required to study the feasibility and physiologic effects of VAC in the setting of hemorrhagic shock. Our experimental approach was to develop an automated extracorporeal circuit that could off-load proximal aortic pressure in the setting of REBOA and deliver distal perfusion, controlling for the variables of flow and pressure. In this context, the hybrid of REBOA and the extracorporeal circuit serve as a surrogate for EVAC. This configuration will allow us to investigate dynamic partial aortic occlusion and permissive regional hypoperfusion in an experimental model. The objective of this study was to describe the experimental setup and examine the feasibility of a combined endovascular-extracorporeal approach to automated VAC in a lethal model of torso hemorrhage and shock.
MATERIALS AND METHODS

Overview of Experimental Design
This study was approved by the Institutional Animal Care and Use Committee at David Grant USAF Medical Center, Travis Air Force Base, California. All animal care and use was in strict compliance with the Guide for the Care and Use of Laboratory Animals in a facility accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International. Healthy adult, castrate male and nonpregnant female Yorkshire-cross swine (Sus scrofa), obtained from the University of California, Davis, were acclimated for a minimum of 7 days. At the time of experimentation, animals weighed between 72 kg and 90 kg, with an age between 5 months and 7 months.
Following severe mixed venous and arterial liver injury and 1.5 minutes of free hemorrhage, animals underwent a 20-minute period of REBOA followed by restoration of variable, low-volume distal aortic flow using the extracorporeal circuit for the duration of 90 minutes (Fig. 1) . Following this 90-minute period of REBOA with automated extracorporeal perfusion (carotid to femoral), surgical hemostasis was performed via a laparotomy. The animal was then weaned from occlusion by gradually restoring flow through the extracorporeal circuit in response to proximal aortic pressure followed by REBOA catheter deflation. As would be the case in a real clinical scenario, these experiments were conducted in an "intention to treat" fashion. Animals unable to tolerate VAC reverted back to standard REBOA for the duration of the 70 minutes as a salvage maneuver.
Animal Preparation
Animals were premedicated with 6.6 mg/kg tiletamine/ zolazepam (TELAZOL, Fort Dodge Animal Health, Fort Dodge, IA) intramuscularly. Following isoflurane induction and endotracheal intubation, maintenance anesthesia consisted of 2% isoflurane in 100% oxygen. To overcome the vasodilatory effects of general anesthesia, an intravenous infusion of norepinephrine (0.01 μg/kg/h) was initiated. Animals were mechanically ventilated with tidal volumes of 7 mL/kg to 10 mL/kg and a respiratory rate of 10 breaths to 15 breaths per minute sufficient to maintain end-tidal CO 2 at 40 ± 5 mm Hg. The pigs were placed on a warming blanked set at 39°C to minimize hypothermia.
Both carotid arteries were exposed through a midline neck incision, the left brachial artery was exposed through an axillary incision, and the femoral arteries were accessed through separate oblique groin incisions. Arterial access was obtained for blood collection as well as proximal and distal hemodynamic monitoring and to facilitate endovascular intervention. A 4-mm perivascular Doppler flow probe (Transonic Corporation, Ithaca, NY) was secured around the right carotid artery to monitor cerebral blood flow. In addition, a 12 Fr 13-cm introducer sheath (Cook Incorporated, Bloomington, IN) was inserted retrograde into the left femoral artery, through which the occlusion balloon catheter was introduced ( Fig. 2A) . Concurrently, a splenectomy was completed to minimize hemodynamic variation from autotransfusion. Normal saline was administered at a maintenance rate of 5 mL/kg per hour.
Development of the VAC Circuit
A custom extracorporeal, automated VAC circuit capable of regulating distal aortic flow was constructed to experimentally replicate the desired functionality of EVAC when combined with REBOA (Fig. 3A) . The automation of the system was developed to facilitate a reliable and reproducible experimental design, minimizing potential for experimental bias. The hardware construct includes a commercially available flow monitor (Transonic Corporation), a novel extracorporeal flow circuit ( Fig. 2A) , and a custom-designed control system (Fig. 3B) . Flow through the circuit was reliant on cardiac output and proximal blood pressure and regulated with a linear actuator that extrinsically compresses the circuit tubing (Fig. 3C ). In this manner, distal aortic flow was controlled across the spectrum from complete occlusion to unimpeded full flow.
The configuration of the circuit was as follows. An 18 Fr cannula was inserted into the left carotid artery and advanced to the level of the aortic arch. A second cannula was inserted retrograde into the left femoral artery to the level of the infrarenal aorta ( Fig. 2A) . These cannulas are connected with 3/8-in internal diameter tubing. To initiate flow through the circuit, REBOA was performed by positioning and inflating a CODA balloon (Cook Medical, Bloomington, IN) at the level of the diaphragm. To achieve distal flow, pneumatic pinch valves were unclamped to allow blood flow from the proximal carotid cannula through the VAC circuit and returning to the animal through the distal transfemoral cannula. Circuit flow rates were assessed with an inline flow meter. The flow rate was precisely regulated to within ±5 mL/min of the prescribed flow rate using the linear actuator. As the actuator extended and retracted, roller bearings on the opposing end of the lever arm variably compressed the tubing with a high degree of fidelity (approximately 0.01-mm step movement of the roller bearing) (Fig. 2B) . A complete technical description of the circuit control design is provided (see Text, Supplemental Digital Content 1, http://links.lww.com/TA/A753).
Injury
The liver was marked along the planned transection plane, 2 cm to the left of Cantlie's line, to provide amputation of approximately 80% of the left lateral lobe of the liver and 40% of the left medial lobe of the liver (approximately 30% of total liver volume) similar to previous descriptions. 10 At Time 0, the liver was sharply transected, and the abdomen was rapidly closed. Complete occlusion of the aorta was achieved with REBOA 1.5 minutes following the initiation of injury (Fig. 2B) .
Intervention
REBOA and Restoration of Distal Aortic Flow with Automated VAC Circuit
Following 20 minutes of REBOA, automated VAC was achieved by reintroducing oxygenated blood flow in a highly controlled fashion through the extracorporeal VAC circuit, around the inflated REBOA catheter, and into the distal aorta according to a predetermined algorithm (see Figure, Supplemental Digital Content 2, http://links.lww.com/TA/A754). Bypassing the inflated REBOA catheter with this circuit resulted in distal regional hypoperfusion for the remaining 70 minutes of the intervention period. During this period, the customized linear actuator on the VAC circuit continuously adjusted the degree of compression of the circuit tubing to maintain a predetermined circuit flow rate provided that mean arterial pressure (MAP) remained above a preset threshold of 50 mm Hg (see Figure, Supplemental Digital Content 2, http://links.lww.com/TA/ A754). Below this threshold, the actuator restricted circuit blood flow to a minimum flow rate of 100 mL/min to prevent death from complete cardiovascular collapse. Furthermore, the VAC circuit was programmed to automatically clamp after 3 minutes of sustained pressure of less than 35 mm Hg, reestablishing complete REBOA for the remainder of the 90-minute intervention period. Conversely, the VAC circuit increased the distal flow rate if a higher proximal MAP threshold was reached following 20 minutes of VAC. The flow rate was dynamic and lww.com/TA/A754). The initial flow rate of 150 mL/min was determined during earlier iterations of model development, in which a flow rate of 150 mL/min after controlled hemorrhage of animals to Class IV shock resulted in a proximal MAP of approximately 60 mm Hg (data not shown). Two colloid boluses were allowed during VAC at T40 and T70, with administration predicated on a minimum MAP threshold and indicated by an audible alarm from the control system. At the conclusion of the 90-minute intervention phase, the abdomen was reopened, and liver hemorrhage was definitively controlled. Shed blood was quantified and fresh whole blood resuscitation was used to replenish the exact total volume of intraabdominal shed blood.
Weaning From REBOA with Automated VAC Circuit and Intensive Care Unit Phase
Ten minutes following the start of damage-control surgery, an automated weaning algorithm was initiated. When the proximal MAP exceeded the minimum threshold of 65 mm Hg, the VAC circuit progressively opened to restore a full flow state. However, the circuit would also maintain or decrease flow to sustain the proximal MAP at greater than 55 mm Hg. Following a 5-minute period of full and unrestricted circuit flow, an alarm sounded to signal successful weaning from occlusion. The VAC circuit was clamped simultaneous to CODA balloon deflation to end REBOA and restore native inline aortic flow. The animal was then survived for 360 minutes from the start of the experiment. During this intensive care unit phase, boluses were administered if the MAP dropped to less than 60 mm Hg continuously for more than 1 minute. The animals were euthanized after 360 minutes.
Data Collection
Physiologic data, including proximal and distal aortic pressures, visceral blood pressure (distal branch of the superior mesenteric artery), heart rate, core body temperature, right carotid artery blood flow, and electrocardiography monitoring were continuously captured throughout the experiment using a multichannel data acquisition system (Biopac Systems Inc., Goleta, CA).
RESULTS
Ex vivo testing of the flow circuit revealed that the circuit and automated control mechanism were able to reliably achieve precise flow across all prescribed algorithms (see Figure A total of 15 experiments were performed as part of this model validation study (6 model development and 9 model validation animals). Animal preparation, liver injury, open surgical technique, and posthemorrhage resuscitation protocols were developed with the initial six model development animals. Two animals in the study group developed large air emboli from the liver injury and were excluded because of instant death after injury. The remaining seven animals constituted the Data from the proximal pressure and inline flow monitors is relayed in real time back to the data acquisition system and on to the control box, which regulates flow in the circuit based on a prescribed algorithm. study cohort. All seven sustained a large liver injury with intraabdominal hemorrhage. The activated clotting time for all animals was close to the desired target of 100 seconds. All seven animals survived to the end of study, and two reverted to complete REBOA during the period of VAC due to sustained hypotension.
Baseline injury characteristics, resuscitation metrics, and outcomes are shown in Table 1 . The two animals that did not tolerate distal flow required reocclusion of the circuit after only 2 minutes and 15 minutes, respectively. An averaged hemodynamic profile for all animals is shown in Figure 4A . The liver injury created a consistent and rapid decrease in the proximal MAP over the 1.5 minutes of free hemorrhage before intervention with a subsequent increase during the initial 20-minute period of complete REBOA. Animals that tolerated distal flow via the VAC circuit during the remaining 70 minutes consistently maintained a proximal MAP of greater than 60 mm Hg (Table 2 ). Furthermore, animals that tolerated sustained flow through the VAC circuit organ demonstrated continued distal organ function following the intervention with sustained urine production and lactate clearance. Animals that tolerated VAC were able to wean from partial flow to full native aortic flow without large fluctuations in proximal MAP (Fig. 4B) .
DISCUSSION
The objective of this study was to demonstrate the feasibility of REBOA coupled with a novel automated extracorporeal circuit to establish a predicate model with which to study the emerging concept of automated EVAC. Findings demonstrate that initiation of this circuit in conjunction with complete REBOA effectively regulates proximal aortic pressure within desirable and predetermined parameters while providing a variable degree of distal aortic perfusion that mitigates ischemia without leading to exsanguination. Observations from this study show complete survival from what is an otherwise uniformly fatal injury with a preserved distal organ function after 90 minutes of intervention and before definitive surgical control of hemorrhage. This study supports the principle of "permissive regional hypoperfusion" in the setting of noncompressible torso hemorrhage, provides a model to study it, and suggests a transforming potential for automated, EVAC in the setting of shock. The advancement of endovascular technologies in response to ongoing clinical and translational research has resulted in the development of REBOA as a viable alternative to traditional thoracotomy and aortic cross-clamping. However, REBOA still results in a significant ischemic insult to distal tissue beds and is only tolerated in short intervals. 3, 11 Extended periods of complete aortic occlusion can result in irreversible ischemic injury, permanent organ failure, limb ischemia, and death. 3, 4 Unfortunately, these consequences restrict the application of REBOA in many clinical scenarios to a technique of last resort. However, EVAC may offer new therapeutic options for noncompressible truncal injury. Similar to REBOA, EVAC would lessen the physiologic impact of aortic occlusion compared with traditional thoracotomy and aortic cross-clamping. In addition, EVAC maneuvers would likely require an abbreviated period of complete aortic occlusion to provide for early hemodynamic recovery and clot stabilization. What distinguishes EVAC from current resuscitative strategies is the early restoration of low volume distal flow to minimize the ischemic burden of sustained complete aortic occlusion. Furthermore, control of an EVAC device with smart technology is conceivable to regulate distal flow based on the patient's physiology. Moreover, the expanded capability of future low-profile endovascular devices would allow EVAC to be applied more liberally and earlier in the patient's care. The results of our current study highlight that this approach is rational and feasible.
The model in this series of experiments was constructed to be a temporary surrogate of automated VAC and not the end solution. While examples exist in cardiovascular surgery of the use of extracorporeal circuits to off-load the left ventricle during aortic cross-clamping and to deliver distal aortic perfusion during an aortic repair, none of them are automated Figure 4 . Hemodynamic data: A, Proximal MAP throughout the experiment. Note that animals requiring crossover sustained precipitous drop upon EVAC but rebounded upon reocclusion. Following damage control, animals that tolerating sustained EVAC maintained a MAP near baseline for the remainder of the study. B, Circuit flow during EVAC phase. Averaged continuous MAP for five animals that tolerated EVAC showed sustained initial flow at 150 mL/min, with flow rate of 300 mL/min beyond T40 and immediately weaned from REBOA. to regulate a desired range of proximal aortic pressure or distal flow and are too cumbersome to be used in settings of trauma. 12, 13 This model confirms the effectiveness of the general approach to left ventricular off-loading and extends the concept to the setting of trauma and shock. In addition, the model in this study, including the pressure-responsive computer algorithm of the circuit, provides a means by which to study the principles of automated VAC and permissive regional hypoperfusion in the setting of torso hemorrhage. The design of this model should also allow for the more efficient development of catheter-based devices including ones to accomplish regulated EVAC.
Our previous attempts to mitigate the deleterious effects of REBOA with existing endovascular technology used a similar porcine liver injury model. 10 A significant limitation of this previous experimental model of partial REBOA with balloon catheters was the inability to quantify or control the amount of blood flow being delivered to the distal aorta. Instead of measuring direct flow, the degree of occlusion was based on the pressure gradient proximal and distal to the balloon. Our current experience suggests an uncoupling of the relationship between pressure gradient and flow particularly during periods when circulating blood volume and/or cardiac output are changing (see Figure, Supplemental Digital Content 4, http://links.lww.com/ TA/A756). This finding led us to surmise that flow rates in previous studies may have exceeded what was physiologically tolerable in the face of an uncontrolled vascular injury. Thus, the lack of current balloon catheter technology to measure and precisely regulate distal aortic flow was the impetus for redesigning the experimental setup and creating an automated computercontrolled model of VAC.
Our bench-top testing has validated the feasibility of tightly regulating flow with computer-controlled algorithms in an ex vivo flow circuit (see Figures, Supplemental Digital Content 3 and 4, http://links.lww.com/TA/A755 and http://links.lww. com/TA/A756). In addition, we have been able to replicate this precise control in our large animal model. Using the described EVAC resuscitation paradigm, we have noted significant improvement in immediate survival for animals undergoing EVAC as compared with previous work with a similar liver injury model. 10 In this present study, all animals survived to the end of the experiment. This suggests that even in critically injured animals, attempts to reinstate partial distal flow did not ultimately compromise short-term salvage of the animal.
Current technologies in endovascular aortic occlusion are dependent on the manual inflation of a REBOA balloon. 6, 14, 15 Small changes in the diameter of an occlusion balloon result in large changes in flow (based on the Poiseuille's Law), making control of distal flow by manual adjustment of balloon diameter extremely difficult. While waiting for the technological advances that will make endovascular graded occlusion of the aorta possible, we have used our extracorporeal circuit as a stepping stone to demonstrate the utility of automated computer control of variable aortic occlusion. The development of catheters capable of EVAC with computer-controlled automation promises a more efficient and responsive system during resuscitation. Furthermore, the creation of an automated endovascular aortic occlusive device will help "cognitively off-load" health care providers and free them to focus efforts on key manual resuscitative interventions, from the preparation of a patient for transport to providing definitive surgical hemorrhage control, while automated aortic control maximizes a patient's physiology.
Automated computer-controlled VAC offers new advances in weaning patients from aortic occlusion. Current methods of weaning a patient from complete aortic occlusion are imprecise and poorly studied. Upon reintroduction of aortic flow, the redistribution of blood with accumulated ischemic metabolites results in ischemia reperfusion injury, systemic inflammatory response, and often hemodynamic collapse. 16, 17 As many as 50% of patients treated with traditional REBOA require reocclusion of the aorta, adding to the existing ischemic burden. 3, 4 Besides minimizing distal ischemia through partial aortic flow, an automated-computer controlled model of EVAC provides an alternative to the dichotomous open or occluded paradigm provided by REBOA. These initial experiments have demonstrated that our weaning protocol is able to rapidly transition from complete occlusion to open flow automatically in less than 20 minutes. The weaning in both animals that required reocclusion of the aorta occurred successfully without hemodynamic collapse using this algorithm despite significant ischemic burden at the time of initiation of weaning. Moreover, the sustained distal aortic flow for the other five animals facilitated immediate weaning from occlusion, presumably because of decreased distal ischemic burden. This rapid return of full aortic flow further underscores how EVAC might minimize the physiologic impact of aortic occlusion.
Beyond translational experiments for hemorrhage, the VAC afforded by this experimental model could be used in polytrauma models to evaluate effects of supraphysiologic blood flow on proximal vascular beds. In particular, this model is ideally suited to evaluate effects of partial and complete aortic occlusion on patients with concomitant traumatic brain injury, a patient group that has fared poorly with traditional REBOA techniques. 3, 4 This expanded capability may even limit the inherent physiologic variation in large animal experiments by providing precise regulation of proximal or distal arterial blood pressure or flow for extended periods. Such applications could accelerate the transition toward more clinically relevant models of traumatic brain injury and ischemia-reperfusion injury.
The present proof-of-concept study is limited by a lack of a comparison group receiving only REBOA for the entire 90-minute intervention phase and prevents broader interpretation of the results. Likewise, these experiments did not include a group in which no intervention was performed after injury. However, our previous experience using a similar liver injury model suggests a uniformly, rapidly fatal injury in the absence of expeditious application of complete REBOA. 10 In addition, the use of large diameter aortic cannulas in the femoral artery likely resulted in flow restriction to the hind limb of the animal and may have artificially increased the ischemic burden. Limitations notwithstanding, this study provides an important first step toward novel resuscitation paradigms and experimental methodology.
CONCLUSION
This study demonstrates the lifesaving potential of a novel, automated, extracorporeal circuit used in conjunction with complete REBOA. Initiation of the extracorporeal circuit in this study regulated proximal aortic pressure within a predetermined range, alleviating supranormal values above the balloon occlusion. This approach also provided controlled distal aortic perfusion that reduced end-organ ischemia without inducing intolerable bleeding, confirming the principle of permissive regional hypoperfusion. The endovascular-extracorporeal approach in this study serves as a temporary surrogate for future automated VAC designs-including the development of lowprofile, endovascular devices-that should be pursued as potentially transformational approaches to noncompressible torso hemorrhage and shock. 
